Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Aarti Pharmalabs Ltd

NSE: AARTIPHARM · BSE: 543748 · Pharmaceuticals & Biotechnology · 34 announcements

Share price
₹954.00
Market cap
₹8,651 Cr
Revenue (annual)
₹1,819 Cr
Net profit (annual)
₹174.7 Cr
P/E (TTM)
40.6×Sector 47.4×
Promoter holding
42.86%-0.22% QoQ
FII holding
8.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:17 IST BSE
Other Announcement

Aarti Pharmalabs Other Announcement

Aarti Pharmalabs Ltd submitted its quarterly compliance certificate under Regulation 74(5) for the period ended March 31, 2026. The registrar, MUFG Intime India, confirmed no dematerialisation requests were received during the quarter. This is a routine regulatory disclosure with no material financial impact.

16:56 IST BSE
Other Announcement

Aarti Pharmalabs Other Announcement

Aarti Pharmalabs Limited launched the 'Saksham Niveshak' campaign from April 1 to July 9, 2026. Initiated by the IEPFA, the drive encourages shareholders to update KYC details and claim unpaid dividends before they are transferred to the Investor Education and Protection Fund.

Execution
April 01, 2026 to July 09, 2026
10:17 IST BSE
Share Pledge

Aarti Pharmalabs Share Pledge

Aarti Pharmalabs promoter Mirik Rajendra Gogri pledged 27,84,094 shares (3.08% stake) to secure a ₹75 Crore loan from Bajaj Financial Securities and 360 One Distribution. The pledged shares have a market value of ₹177.90 Crore, representing a security cover of 2.37x.

Value
₹75.00 Cr
10:17 IST BSE
Share Pledge

Aarti Pharmalabs Share Pledge

Mr. Renil Rajendra Gogri, a promoter of Aarti Pharmalabs Ltd, created a pledge on 15,19,919 shares (3.89% of share capital) valued at ₹97.12 Crore. The pledge was created in favour of Aditya Birla Money, Bajaj Financial Securities, and 360 One Distribution Services for personal use.

Value
₹97.12 Cr